CAS No. 148412-04-8

Ribonucleicacid formation factor E 2F 1 (human clone RBP3 reduced)

Catalog No.	744548
Name	Ribonucleicacid formation factor E 2F 1 (human clone RBP3 reduced)
CAS	148412-04-8

Request a Quote SDS

About Ribonucleicacid formation factor E 2F 1 (human clone RBP3 reduced)

Ribonucleicacid formation factor E 2F 1 (human clone RBP3 reduced) is a chemical compound registered under CAS number 148412-04-8. It is also known as 13: PN: US6159691SEQID: 13 unclaimed protein; 1: PN: US6074850 SEQID: 1 unclaimed protein; GeneE2 promoter-specific factor (human isoform E2F-1). KingPharm Group supplies Ribonucleicacid formation factor E 2F 1 (human clone RBP3 reduced) for laboratory research and bulk production; product code 744548. Send an inquiry for purity, packaging, price and lead time.

CAS Number: 148412-04-8

Synonyms

13: PN: US6159691SEQID: 13 unclaimed protein
1: PN: US6074850 SEQID: 1 unclaimed protein
GeneE2 promoter-specific factor (human isoform E2F-1)
RNA formation factor RBAP-1(human cel

Related Keywords

human

clone

factor

reduced

formation

ribonucleicacid

2,5-Anhydro-3-O,4-O,6-O-tribenzoyl-D-allose oxime

2-CYCLOHEXEN-1-ONE,4-HYDROPEROXY-4-(ISOPROPYL)-

3,5-Pyridinedicarboxylic acid,6-amino-2-ethoxy-3,4-dihydro-4-[4-(methylthio)phenyl]-, diethyl ester

9,12-Hexadecadienoic acid, (9Z,12Z)-

1-Butanone,1-[4-(1,1-dimethylethyl)phenyl]-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-, oxime

2-Butanone, 4-(6-methyl-1-cyclohexen-1-yl)-

87842-56-6

2,2':5',2'':5'',2''':5''',2'''':5'''',2'''''-Sexithiophene, 5,5'''''-dioctyl-

3-Buten-2-one, 1-chloro-1,1-difluoro-4-[(4-methylphenyl)amino]-, (3Z)-

Acetic acid, [(2-nitrophenyl)thio]-, methyl ester

Oxirane,2-(3-chloro-4-methyl-4-pentenyl)-3-[(4-ethylphenoxy)methyl]-2-methyl-

Methanone, (2-ethoxycyclopropyl)phenyl-, trans-

Benzenepropanal, b-mercapto-

50707-86-3

Benzene, [(1R,2R)-2-methylcyclopropyl]-, rel-

Acetylbromide

3(2H)-Indolizinone, 1,7,8,8a-tetrahydro-7-methyl-, cis-

audouine

2,4-Pentadienal,5-[(2S,3S,8S)-8-hydroxy-2,3,7,9,9-pentamethyl-1,4-dioxaspiro[4.5]dec-6-en-8-yl]-3-methyl-, (2Z,4E)-

Hexanamide, N-[bi-1-cyclohexen-1-yl]-2-yl-

50697-47-7

Benzene, 1-[(6-chloro-3,7-dimethyl-2,7-octadienyl)oxy]-4-ethyl-, (E)-

sulfuric acid

6-[(2-chlorobenzyl)sulfanyl]-5H-purin-2-amine

Docosylvinyl ether

2-Buten-1-amine, N-(acetyloxy)-

CARBAMODITHIOIC ACID (2-AMINOETHYL)METHYL-

507231-27-8

RESTRICTION ENDONUCLEASES DRA I

bis(1,1-dimethylpropyl)naphthalene

Benzene, [2-(1,1-dimethylethyl)-2-methoxycyclopropyl]-, trans-

3,5-Pyridinedicarboxylic acid,6-amino-4-(3-chlorophenyl)-2-ethoxy-3,4-dihydro-, dimethyl ester

2-[(E)-(5-oxopyridin-2(5H)-ylidene)methyl]hydrazinecarboxamide

D-Alanine,N-[2-[4-[(2R,3R)-3-[[2-(4-chloro-3-methylphenyl)-2-hydroxyethyl]thio]-1-(4-fluorophenyl)-4-oxo-2-azetidinyl]phenoxy]acetyl]glycyl-3-cyclohexyl-

917753-17-4

3,5-Pyridinedicarboxylic acid,6-amino-4-(2-chloro-5-nitrophenyl)-2-ethoxy-3,4-dihydro-, diethyl ester

METHYL-2,3:4,6-DI-O-ISOPROPYLIDENE-D-MANNOPYRANOSIDE

tetrahydrofurfuryl mercaptan

Carbamic acid,[(2R,3S)-2-(4-methoxyphenyl)-1-(4-methylphenyl)-4-oxo-3-azetidinyl]-,phenylmethyl ester, rel-

3-Hydroxy-1-methyl-4(1H)-pyridinone

1(2H)-Azulenone, octahydro-8a-methyl-, cis-